Protein tyrosine phosphatases
play an integral role within the insulin signaling cascade by negatively regulating signal transduction.
Single nucleotide polymorphism in protein tyrosine phosphatase
PTP-1B is associated with protection from diabetes or impaired glucose tolerance.
Tyrogene's second technology platform offers the ability to rapidly identify and validate additional protein tyrosine phosphatase
About CEPTYR: CEPTYR is a private biopharmaceutical company and a world leader in the field of protein tyrosine phosphatase
The role for protein tyrosine phosphatase
nonreceptor type 2 in regulating autophagosome formation
AKB-9778, a first-in-class human protein tyrosine phosphatase
beta (HPTP) inhibitor, works to activate Tie2, a receptor on vascular endothelial cells that promotes vascular stability, preventing abnormal blood vessel growth and vascular leak.
AKB-9778 works by inhibiting the Human Protein Tyrosine Phosphatase
(HPTP) enzyme which acts as a negative regulator of the Tie-2 receptor.
a small molecule discovery and development company focused on anemia and vascular disorders, today announced that it has dosed the first subjects in a first-in-man Phase 1 study of AKB-9778, a first-in-class human protein tyrosine phosphatase
beta (HPTP) inhibitor in development for diabetic macular edema (DME) and diabetic retinopathy (DR).
The paper, "Targeting protein tyrosine phosphatase
after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias," has implications for patients who survive a heart attack, and remain at risk for severe cardiac arrhythmias and sudden cardiac death.
VioQuest Pharmaceuticals licensed rights to sodium stibogluconate from the Cleveland Clinic Foundation and is developing the drug as a protein tyrosine phosphatase
inhibitor for a range of potential indications.
Receptor signaling protein tyrosine phosphatase
The abstract from the Lenocta study, entitled "Phase I dose-escalation study of sodium stibogluconate (SSG), a protein tyrosine phosphatase
inhibitor, combined with interferon-alpha for patients with solid tumors" (abstract #3011), is available on the ASCO website at www.